Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 300

1.

Association of Midlife to Late-Life Blood Pressure Patterns With Incident Dementia.

Walker KA, Sharrett AR, Wu A, Schneider ALC, Albert M, Lutsey PL, Bandeen-Roche K, Coresh J, Gross AL, Windham BG, Knopman DS, Power MC, Rawlings AM, Mosley TH, Gottesman RF.

JAMA. 2019 Aug 13;322(6):535-545. doi: 10.1001/jama.2019.10575.

PMID:
31408138
2.

Association of sickle cell trait with measures of cognitive function and dementia in African Americans.

Chen N, Caruso C, Alonso A, Derebail VK, Kshirsagar AV, Sharrett AR, Key NS, Gottesman RF, Grove ML, Bressler J, Boerwinkle E, Windham BG, Mosley TH Jr, Hyacinth HI.

eNeurologicalSci. 2019 Jul 22;16:100201. doi: 10.1016/j.ensci.2019.100201. eCollection 2019 Sep.

3.

Authors' Reply.

Chu NM, Gross AL, Shaffer AA, Haugen CE, Norman SP, Xue QL, Sharrett AR, Carlson M, Bandeen-Roche K, Segev DL, McAdams-DeMarco MA.

J Am Soc Nephrol. 2019 Aug;30(8):1548-1549. doi: 10.1681/ASN.2019050447. Epub 2019 Jul 12. No abstract available.

PMID:
31300483
4.

The Association of Late-Life Diabetes Status and Hyperglycemia With Incident Mild Cognitive Impairment and Dementia: The ARIC Study.

Rawlings AM, Sharrett AR, Albert MS, Coresh J, Windham BG, Power MC, Knopman DS, Walker K, Burgard S, Mosley TH, Gottesman RF, Selvin E.

Diabetes Care. 2019 Jul;42(7):1248-1254. doi: 10.2337/dc19-0120. Epub 2019 May 21.

PMID:
31221696
5.

Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment.

Wu A, Sharrett AR, Gottesman RF, Power MC, Mosley TH Jr, Jack CR Jr, Knopman DS, Windham BG, Gross AL, Coresh J.

JAMA Netw Open. 2019 May 3;2(5):e193359. doi: 10.1001/jamanetworkopen.2019.3359.

6.

Cognitive Reserve in Midlife is not Associated with Amyloid-β Deposition in Late-Life.

Rawlings AM, Sharrett AR, Mosley TH, Wong DF, Knopman DS, Gottesman RF.

J Alzheimers Dis. 2019;68(2):517-521. doi: 10.3233/JAD-180785.

PMID:
30775981
7.

Neural correlates of domain-specific cognitive decline: The ARIC-NCS Study.

Schneider ALC, Senjem ML, Wu A, Gross A, Knopman DS, Gunter JL, Schwarz CG, Mosley TH, Gottesman RF, Sharrett AR, Jack CR Jr.

Neurology. 2019 Mar 5;92(10):e1051-e1063. doi: 10.1212/WNL.0000000000007042. Epub 2019 Feb 6.

PMID:
30728308
8.

Prevalence of Retinal Signs and Association With Cognitive Status: The ARIC Neurocognitive Study.

Lee MJ, Deal JA, Ramulu PY, Sharrett AR, Abraham AG.

J Am Geriatr Soc. 2019 Jun;67(6):1197-1203. doi: 10.1111/jgs.15795. Epub 2019 Feb 1.

PMID:
30706941
9.

Frailty and Changes in Cognitive Function after Kidney Transplantation.

Chu NM, Gross AL, Shaffer AA, Haugen CE, Norman SP, Xue QL, Sharrett AR, Carlson MC, Bandeen-Roche K, Segev DL, McAdams-DeMarco MA.

J Am Soc Nephrol. 2019 Feb;30(2):336-345. doi: 10.1681/ASN.2018070726. Epub 2019 Jan 24.

PMID:
30679381
10.

Central Arterial Stiffness Is Associated With Structural Brain Damage and Poorer Cognitive Performance: The ARIC Study.

Palta P, Sharrett AR, Wei J, Meyer ML, Kucharska-Newton A, Power MC, Deal JA, Jack CR, Knopman D, Wright J, Griswold M, Tanaka H, Mosley TH, Heiss G.

J Am Heart Assoc. 2019 Jan 22;8(2):e011045. doi: 10.1161/JAHA.118.011045.

11.

Retinal signs and risk of incident dementia in the Atherosclerosis Risk in Communities study.

Deal JA, Sharrett AR, Albert M, Bandeen-Roche K, Burgard S, Thomas SD, Gottesman RF, Knopman D, Mosley T, Klein B, Klein R.

Alzheimers Dement. 2019 Mar;15(3):477-486. doi: 10.1016/j.jalz.2018.10.002. Epub 2018 Nov 12.

PMID:
30439332
12.

Leisure-time physical activity sustained since midlife and preservation of cognitive function: The Atherosclerosis Risk in Communities Study.

Palta P, Sharrett AR, Deal JA, Evenson KR, Gabriel KP, Folsom AR, Gross AL, Windham BG, Knopman D, Mosley TH, Heiss G.

Alzheimers Dement. 2019 Feb;15(2):273-281. doi: 10.1016/j.jalz.2018.08.008. Epub 2018 Oct 12.

PMID:
30321503
13.

Carotid Artery Wall Thickness and Incident Cardiovascular Events: A Comparison between US and MRI in the Multi-Ethnic Study of Atherosclerosis (MESA).

Zhang Y, Guallar E, Malhotra S, Astor BC, Polak JF, Qiao Y, Gomes AS, Herrington DM, Sharrett AR, Bluemke DA, Wasserman BA.

Radiology. 2018 Dec;289(3):649-657. doi: 10.1148/radiol.2018173069. Epub 2018 Oct 9.

PMID:
30299234
14.

Serum Vitamin D Concentrations and Cognitive Change Over 20 Years: The Atherosclerosis Risk in Communities Neurocognitive Study.

Schneider ALC, Zhao D, Lutsey PL, Gottesman RF, Sharrett AR, Rawlings AM, Alonso A, Knopman D, Mosley TH, Selvin E, Michos ED.

Neuroepidemiology. 2018;51(3-4):131-137. doi: 10.1159/000490912. Epub 2018 Aug 9.

15.

Association of orthostatic hypotension with incident dementia, stroke, and cognitive decline.

Rawlings AM, Juraschek SP, Heiss G, Hughes T, Meyer ML, Selvin E, Sharrett AR, Windham BG, Gottesman RF.

Neurology. 2018 Aug 21;91(8):e759-e768. doi: 10.1212/WNL.0000000000006027. Epub 2018 Jul 25.

16.

Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study.

Lee AK, Rawlings AM, Lee CJ, Gross AL, Huang ES, Sharrett AR, Coresh J, Selvin E.

Diabetologia. 2018 Sep;61(9):1956-1965. doi: 10.1007/s00125-018-4668-1. Epub 2018 Jun 30.

17.

Application of Optical Coherence Tomography in the Detection and Classification of Cognitive Decline.

Lee MJ, Abraham AG, Swenor BK, Sharrett AR, Ramulu PY.

J Curr Glaucoma Pract. 2018 Jan-Apr;12(1):10-18. doi: 10.5005/jp-journals-10028-1238. Epub 2018 Mar 1. Review.

18.

Midlife vascular risk factors and midlife cognitive status in relation to prevalence of mild cognitive impairment and dementia in later life: The Atherosclerosis Risk in Communities Study.

Knopman DS, Gottesman RF, Sharrett AR, Tapia AL, DavisThomas S, Windham BG, Coker L, Schneider ALC, Alonso A, Coresh J, Albert MS, Mosley TH Jr.

Alzheimers Dement. 2018 Nov;14(11):1406-1415. doi: 10.1016/j.jalz.2018.03.011. Epub 2018 May 12.

PMID:
29763593
19.

Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.

Ding N, Kwak L, Ballew SH, Jaar B, Hoogeveen RC, Ballantyne CM, Sharrett AR, Folsom AR, Heiss G, Salameh M, Coresh J, Hirsch AT, Selvin E, Matsushita K.

Atherosclerosis. 2018 Jul;274:86-93. doi: 10.1016/j.atherosclerosis.2018.04.042. Epub 2018 Apr 30.

20.

Olfactory function and neurocognitive outcomes in old age: The Atherosclerosis Risk in Communities Neurocognitive Study.

Palta P, Chen H, Deal JA, Sharrett AR, Gross A, Knopman D, Griswold M, Heiss G, Mosley TH.

Alzheimers Dement. 2018 Aug;14(8):1015-1021. doi: 10.1016/j.jalz.2018.02.019. Epub 2018 Mar 30.

21.

High-sensitivity cardiac troponin and natriuretic peptide with risk of lower-extremity peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) Study.

Matsushita K, Kwak L, Yang C, Pang Y, Ballew SH, Sang Y, Hoogeveen RC, Jaar BG, Selvin E, Ballantyne CM, Sharrett AR, Folsom AR, Heiss G, Coresh J, Hirsch AT.

Eur Heart J. 2018 Jul 1;39(25):2412-2419. doi: 10.1093/eurheartj/ehy106.

22.

Cognitive impairment and intracranial atherosclerotic stenosis in general population.

Suri MFK, Zhou J, Qiao Y, Chu H, Qureshi AI, Mosley T, Gottesman RF, Wruck L, Sharrett AR, Alonso A, Wasserman BA.

Neurology. 2018 Apr 3;90(14):e1240-e1247. doi: 10.1212/WNL.0000000000005250. Epub 2018 Mar 9.

23.

Retinal signs and 20-year cognitive decline in the Atherosclerosis Risk in Communities Study.

Deal JA, Sharrett AR, Rawlings AM, Gottesman RF, Bandeen-Roche K, Albert M, Knopman D, Selvin E, Wasserman BA, Klein B, Klein R.

Neurology. 2018 Mar 27;90(13):e1158-e1166. doi: 10.1212/WNL.0000000000005205. Epub 2018 Feb 28.

24.

Prevalence and correlates of depressive symptoms in older adults across the glycaemic spectrum: the Atherosclerosis Risk in Communities (ARIC) study.

Rawlings AM, Sharrett AR, Golden SH, Windham BG, Selvin E.

Diabet Med. 2018 May;35(5):583-587. doi: 10.1111/dme.13593. Epub 2018 Feb 18.

25.

The Association of Severe Hypoglycemia With Incident Cardiovascular Events and Mortality in Adults With Type 2 Diabetes.

Lee AK, Warren B, Lee CJ, McEvoy JW, Matsushita K, Huang ES, Sharrett AR, Coresh J, Selvin E.

Diabetes Care. 2018 Jan;41(1):104-111. doi: 10.2337/dc17-1669. Epub 2017 Nov 10.

26.

A randomized feasibility pilot trial of hearing treatment for reducing cognitive decline: Results from the Aging and Cognitive Health Evaluation in Elders Pilot Study.

Deal JA, Albert MS, Arnold M, Bangdiwala SI, Chisolm T, Davis S, Eddins A, Glynn NW, Goman AM, Minotti M, Mosley T, Rebok GW, Reed N, Rodgers E, Sanchez V, Sharrett AR, Coresh J, Lin FR.

Alzheimers Dement (N Y). 2017 Jun 21;3(3):410-415. doi: 10.1016/j.trci.2017.06.003. eCollection 2017 Sep.

27.

Neuroimaging Correlates of Cerebral Microbleeds: The ARIC Study (Atherosclerosis Risk in Communities).

Graff-Radford J, Simino J, Kantarci K, Mosley TH Jr, Griswold ME, Windham BG, Sharrett AR, Albert MS, Gottesman RF, Jack CR Jr, Vemuri P, Knopman DS.

Stroke. 2017 Nov;48(11):2964-2972. doi: 10.1161/STROKEAHA.117.018336. Epub 2017 Oct 10.

28.

Metabolomics and cognition in African American adults in midlife: the atherosclerosis risk in communities study.

Bressler J, Yu B, Mosley TH, Knopman DS, Gottesman RF, Alonso A, Sharrett AR, Wruck LM, Boerwinkle E.

Transl Psychiatry. 2017 Jul 18;7(7):e1173. doi: 10.1038/tp.2017.118.

29.

Risk Factors for Severe Hypoglycemia in Black and White Adults With Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study.

Lee AK, Lee CJ, Huang ES, Sharrett AR, Coresh J, Selvin E.

Diabetes Care. 2017 Dec;40(12):1661-1667. doi: 10.2337/dc17-0819. Epub 2017 Sep 19.

30.

Diabetes, Prediabetes, and Brain Volumes and Subclinical Cerebrovascular Disease on MRI: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS).

Schneider ALC, Selvin E, Sharrett AR, Griswold M, Coresh J, Jack CR Jr, Knopman D, Mosley T, Gottesman RF.

Diabetes Care. 2017 Nov;40(11):1514-1521. doi: 10.2337/dc17-1185. Epub 2017 Sep 15.

31.

Association of midlife lipids with 20-year cognitive change: A cohort study.

Power MC, Rawlings A, Sharrett AR, Bandeen-Roche K, Coresh J, Ballantyne CM, Pokharel Y, Michos ED, Penman A, Alonso A, Knopman D, Mosley TH, Gottesman RF.

Alzheimers Dement. 2018 Feb;14(2):167-177. doi: 10.1016/j.jalz.2017.07.757. Epub 2017 Sep 12.

32.

Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort.

Gottesman RF, Albert MS, Alonso A, Coker LH, Coresh J, Davis SM, Deal JA, McKhann GM, Mosley TH, Sharrett AR, Schneider ALC, Windham BG, Wruck LM, Knopman DS.

JAMA Neurol. 2017 Oct 1;74(10):1246-1254. doi: 10.1001/jamaneurol.2017.1658.

33.

Physical Activity in Midlife is not Associated with Cognitive Health in Later Life Among Cognitively Normal Older Adults.

Gross AL, Lu H, Meoni L, Gallo JJ, Schrack JA, Sharrett AR.

J Alzheimers Dis. 2017;59(4):1349-1358. doi: 10.3233/JAD-170290.

PMID:
28759969
34.

Midlife and Late-Life Vascular Risk Factors and White Matter Microstructural Integrity: The Atherosclerosis Risk in Communities Neurocognitive Study.

Power MC, Tingle JV, Reid RI, Huang J, Sharrett AR, Coresh J, Griswold M, Kantarci K, Jack CR Jr, Knopman D, Gottesman RF, Mosley TH.

J Am Heart Assoc. 2017 May 18;6(5). pii: e005608. doi: 10.1161/JAHA.117.005608.

35.

Diabetes and Cognitive Decline in Older Adults: The Ginkgo Evaluation of Memory Study.

Palta P, Carlson MC, Crum RM, Colantuoni E, Sharrett AR, Yasar S, Nahin RL, DeKosky ST, Snitz B, Lopez O, Williamson JD, Furberg CD, Rapp SR, Golden SH.

J Gerontol A Biol Sci Med Sci. 2017 Dec 12;73(1):123-130. doi: 10.1093/gerona/glx076.

36.

Glucose Peaks and the Risk of Dementia and 20-Year Cognitive Decline.

Rawlings AM, Sharrett AR, Mosley TH, Ballew SH, Deal JA, Selvin E.

Diabetes Care. 2017 Jul;40(7):879-886. doi: 10.2337/dc16-2203. Epub 2017 May 12.

37.

Coronary Artery Calcium and Risk of Dementia in MESA (Multi-Ethnic Study of Atherosclerosis).

Fujiyoshi A, Jacobs DR Jr, Fitzpatrick AL, Alonso A, Duprez DA, Sharrett AR, Seeman T, Blaha MJ, Luchsinger JA, Rapp SR.

Circ Cardiovasc Imaging. 2017 May;10(5). pii: e005349. doi: 10.1161/CIRCIMAGING.116.005349.

38.

Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.

Gottesman RF, Schneider AL, Zhou Y, Coresh J, Green E, Gupta N, Knopman DS, Mintz A, Rahmim A, Sharrett AR, Wagenknecht LE, Wong DF, Mosley TH.

JAMA. 2017 Apr 11;317(14):1443-1450. doi: 10.1001/jama.2017.3090.

39.

Postprandial lipemia and the risk of coronary heart disease and stroke: the Atherosclerosis Risk in Communities (ARIC) Study.

Kats D, Sharrett AR, Ginsberg HN, Nambi V, Ballantyne CM, Hoogeveen RC, Heiss G.

BMJ Open Diabetes Res Care. 2017 Feb 1;5(1):e000335. doi: 10.1136/bmjdrc-2016-000335. eCollection 2017.

40.

Prospective associations of plasma phospholipids and mild cognitive impairment/dementia among African Americans in the ARIC Neurocognitive Study.

Li D, Misialek JR, Boerwinkle E, Gottesman RF, Sharrett AR, Mosley TH, Coresh J, Wruck LM, Knopman DS, Alonso A.

Alzheimers Dement (Amst). 2016 Nov 1;6:1-10. doi: 10.1016/j.dadm.2016.09.003. eCollection 2017.

41.

Incident Heart Failure and Cognitive Decline: The Atherosclerosis Risk in Communities Study.

Bressler J, Knopman DS, Sharrett AR, Gottesman RF, Penman A, Chang PP, Rosamond WD, Boerwinkle E, Mosley TH.

J Card Fail. 2017 Jan;23(1):47-55. doi: 10.1016/j.cardfail.2016.11.002. Epub 2016 Nov 15.

42.

Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study.

Agarwala A, Virani S, Couper D, Chambless L, Boerwinkle E, Astor BC, Hoogeveen RC, Coresh J, Sharrett AR, Folsom AR, Mosley T, Ballantyne CM, Nambi V.

Atherosclerosis. 2016 Oct;253:156-163. doi: 10.1016/j.atherosclerosis.2016.08.028. Epub 2016 Aug 25.

43.

Multiple imputation of cognitive performance as a repeatedly measured outcome.

Rawlings AM, Sang Y, Sharrett AR, Coresh J, Griswold M, Kucharska-Newton AM, Palta P, Wruck LM, Gross AL, Deal JA, Power MC, Bandeen-Roche KJ.

Eur J Epidemiol. 2017 Jan;32(1):55-66. doi: 10.1007/s10654-016-0197-8. Epub 2016 Sep 12.

44.

Association of a Biomarker of Glucose Peaks, 1,5-Anhydroglucitol, With Subclinical Cardiovascular Disease.

Liang M, McEvoy JW, Chen Y, Sharrett AR, Selvin E.

Diabetes Care. 2016 Oct;39(10):1752-9. doi: 10.2337/dc16-0840. Epub 2016 Aug 1.

45.

Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study.

Lazo M, Chen Y, McEvoy JW, Ndumele C, Konety S, Ballantyne CM, Sharrett AR, Selvin E.

Clin Chem. 2016 Sep;62(9):1202-10. doi: 10.1373/clinchem.2016.255778. Epub 2016 Jul 20.

46.

Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC-NCS).

Li D, Misialek JR, Boerwinkle E, Gottesman RF, Sharrett AR, Mosley TH, Coresh J, Wruck LM, Knopman DS, Alonso A.

Alzheimers Dement (Amst). 2016 May 6;3:73-82. doi: 10.1016/j.dadm.2016.02.008. eCollection 2016.

47.

The ARIC-PET amyloid imaging study: Brain amyloid differences by age, race, sex, and APOE.

Gottesman RF, Schneider AL, Zhou Y, Chen X, Green E, Gupta N, Knopman DS, Mintz A, Rahmim A, Sharrett AR, Wagenknecht LE, Wong DF, Mosley TH Jr.

Neurology. 2016 Aug 2;87(5):473-80. doi: 10.1212/WNL.0000000000002914. Epub 2016 Jul 1.

48.

Determinants of minimal elevation in high-sensitivity cardiac troponin T in the general population.

Rubin J, Matsushita K, Lazo M, Ballantyne CM, Nambi V, Hoogeveen R, Sharrett AR, Blumenthal RS, Coresh J, Selvin E.

Clin Biochem. 2016 Jun;49(9):657-662. doi: 10.1016/j.clinbiochem.2016.01.024. Epub 2016 Mar 11.

49.

Factor structure of the ARIC-NCS Neuropsychological Battery: An evaluation of invariance across vascular factors and demographic characteristics.

Rawlings AM, Bandeen-Roche K, Gross AL, Gottesman RF, Coker LH, Penman AD, Sharrett AR, Mosley TH.

Psychol Assess. 2016 Dec;28(12):1674-1683. doi: 10.1037/pas0000293. Epub 2016 Mar 10.

50.

Mild Cognitive Impairment and Dementia Prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS).

Knopman DS, Gottesman RF, Sharrett AR, Wruck LM, Windham BG, Coker L, Schneider AL, Hengrui S, Alonso A, Coresh J, Albert MS, Mosley TH Jr.

Alzheimers Dement (Amst). 2016;2:1-11.

Supplemental Content

Loading ...
Support Center